Mometasone Furoate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

97 API Suppliers, 36 USDMF, 28 CEP/COS, 9 JDMF, 19 EU WC, 9 KDMF, 31 NDC API, 50 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

93 Drugs in Development

93 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

371 FDF Dossiers, 41 FDA Orange Book, 183 Europe, 21 Canada, 59 Australia, 29 South Africa, 38 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.1%, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.05MG/INH, AEROSOL, METERED;INHALATION - 0.10MG/INH, AEROSOL, METERED;INHALATION - 0.20MG/INH, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INHALATION - 0.11MG/INH, POWDER;INHALATION - 0.22MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 1 SPI Pharma, 5 DKSH, 2 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 6 Kirsch Pharma, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 4 BASF, 1 CD Formulation, 3 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Ideal Cures, 5 Kerry, 2 Keval Exports, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 9 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 Silverline Chemicals, 1 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Solubilizers, 20 Thickeners and Stabilizers, 17 Parenteral, 16 Fillers, Diluents & Binders, 16 Direct Compression, 11 Topical, 9 Coating Systems & Additives, 9 Film Formers & Plasticizers, 9 Granulation, 8 Co-Processed Excipients, 6 Rheology Modifiers, 5 Disintegrants & Superdisintegrants, 5 Emulsifying Agents, 4 Taste Masking, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents, 3 Controlled & Modified Release, 2 Lubricants & Glidants, 2 Coloring Agents, 1 API Stability Enhancers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 49 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 57 Regulatory FDF Prices, 16 Annual Reports

MARKET PLACE

17 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

23 US Patents, 1 US Exclusivities, 34 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 2 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20762 / DOSAGE - SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
MOMETASONE FUROATE MONOHYDRATE(UNII: MTW0WEG809) (Mometasone - UNII:8HR4QJ6DW8)	Mometasone	50ug

Inactive Ingredients

Ingredient Name	A-S Medication Solutions	Merck Sharp & Dohme Corp.	REMEDYREPACK INC.	Sandoz Inc.
BENZALKONIUM CHLORIDE(F5UM2KM3W7)
CARBOXYMETHYLCELLULOSE SODIUM(K679OBS311)
carboxymethylcellulose sodium, unspecified form(K679OBS311)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
citric acid monohydrate(2968PHW8QP)
glycerin(PDC6A3C0OX)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYSORBATE 80(6OZP39ZG8H)
SODIUM CITRATE(1Q73Q2JULR)
SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR)

Setid 12df48a0 Fd2e 4e1c B135 E616a1f31f42 Applno 20762 Form Spray Metered Nasal Dosage 0 05mg Spray - Drug Product Composition: Mometasone Furoate